Clear Intradermal Technologies, Inc. — Form D
Clear Intradermal Technologies, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-25. The offering totals $1.4M, of which $1.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-10-25
- Form: D
- Accession: 0001757063-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.4M
- Amount sold: $1.2M
- Remaining: $177K
- Investors: 14
- Date of first sale: 2018-10-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-324300
Issuer
- Name: Clear Intradermal Technologies, Inc.
- CIK: 0001757063
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 315 MADISON AVENUE, 3RD FLOOR, NEW YORK, NY, 10017
- Phone: 646-979-3679
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| James W Winkelman, M.D. | Director | Marblehead, MA |
| Gordon E Nye | Director | NEW YORK, NY |
| Martin E Schmieg | Director | Marblehead, MA |
| Martin E Schmieg | Executive Officer | Marblehead, MA |
| James E Winkelman, M.D. | Director | Marblehead, MA |
| James E Winkelman, M.D. | Executive Officer | Marblehead, MA |
| James E Winkelman, M.D | Director | Marblehead, MA |
| James E Winkelman, M.D | Executive Officer | Marblehead, MA |
Other filings by this issuer (5)
More